{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:32:49Z","timestamp":1789763569920,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3817,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jpainsymman.2008.08.007","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T17:54:44Z","timestamp":1238435684000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Age and Racial\/Ethnic Differences in the Prevalence of Reported Symptoms in Human Immunodeficiency Virus-Infected Persons on Antiretroviral Therapy"],"prefix":"10.1016","volume":"38","author":[{"given":"Michael J.","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa P.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey L.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory D.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Gange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2008.08.007_bib1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators","volume":"280","author":"Detels","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00002030-200302140-00009","article-title":"Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category","volume":"17","author":"Perez-Hoyos","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(03)14570-9","article-title":"Determinants of survival following HIV-1 seroconversion after the introduction of HAART","volume":"362","author":"Porter","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/01.aids.0000237369.41617.0f","article-title":"Effectiveness of highly-active antiretroviral therapy by race\/ethnicity","volume":"20","author":"Silverberg","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/aje\/154.7.675","article-title":"Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts","volume":"154","author":"Tarwater","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"10.1016\/j.jpainsymman.2008.08.007_bib6","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/00126334-200306012-00003","article-title":"AIDS and older Americans at the end of the twentieth century","volume":"33","author":"Mack","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib7","first-page":"1149","article-title":"Trends in HIV\/AIDS diagnoses\u201433 states, 2001-2004","volume":"54","author":"Espinoza","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/QAI.0b013e3181609da8","article-title":"Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study)","volume":"47","author":"Tedaldi","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00042560-200003010-00004","article-title":"Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group","volume":"23","author":"Bonfanti","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00042560-200008010-00003","article-title":"Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The AIDS Clinical Trials Group 175 Team","volume":"24","author":"Currier","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0140-6736(01)06413-3","article-title":"Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study","volume":"358","author":"Fellay","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-131-2-199907200-00002","article-title":"Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions","volume":"131","author":"Lucas","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9343(96)00077-0","article-title":"Adverse events from drug therapy for human immunodeficiency virus disease","volume":"101","author":"Moore","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/423181","article-title":"Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study","volume":"39","author":"Silverberg","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jpainsymman.2008.08.007_bib15","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1097\/00126334-200306012-00005","article-title":"Differences in symptom expression in older HIV-positive patients: the Veterans Aging Cohort 3 Site Study and HIV Cost and Service Utilization Study experience","volume":"33","author":"Zingmond","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1089\/08892220152596551","article-title":"Thrush and fever as markers of immune competence in the era of highly active antiretroviral therapy","volume":"17","author":"Skolasky","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jpainsymman.2005.04.011","article-title":"Patient reports of symptoms and their treatment at three palliative care projects servicing individuals with HIV\/AIDS","volume":"30","author":"Karus","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":"The Women's Interagency HIV Study. WIHS Collaborative Study Group","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/aje\/126.2.310","article-title":"The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants","volume":"126","author":"Kaslow","year":"1987","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib20","author":"US Department of Health and Human Services"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib21","series-title":"Analysis of longitudinal data","author":"Diggle","year":"1995"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib24","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/317477","article-title":"Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidemiologie Clinique du Syndrome d'Immunodeficience Acquise en Aquitaine","volume":"31","author":"Thiebaut","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1468-1293.2005.00319.x","article-title":"Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy","volume":"6","author":"Henderson","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0885-3924(02)00676-0","article-title":"Prevalence and correlates of fatigue among persons with HIV infection","volume":"25","author":"Sullivan","year":"2003","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2008.08.007_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/105477380201100106","article-title":"Characteristics of nausea reported by HIV-infected patients initiating combination antiretroviral regimens","volume":"11","author":"Reynolds","year":"2002","journal-title":"Clin Nurs Res"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392409000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392409000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:00:49Z","timestamp":1760130049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392409000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0885392409000633"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.08.007","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age and Racial\/Ethnic Differences in the Prevalence of Reported Symptoms in Human Immunodeficiency Virus-Infected Persons on Antiretroviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2008.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}